meta
|
evidence
oncology
Living systematic review and meta-analysis
breast cancer - HER2-positive
es-BC - HER2 negative - (neo)adjuvant (NA)
1
es-BC - HER2 positive - (neo)adjuvant (NA)
4
la/mBC - HER2 positive
la/mBC - HER2 positive - (neo)adjuvant (NA)
la/mBC - HER2 positive - 1st Line (L1)
5
la/mBC - HER2 positive - 2nd Line (L2)
13
HER inhibitor
HER2 inhibitor
trastuzumab based treatment
trastuzumab plus chemotherapy
TKI anti HER1/EGFR and HER2/neu
lapatinib based treatment
lapatinib plus paclitaxel
lapatinib plus trastuzumab plus paclitaxel
no study with result for this clinical condition